Security Snapshot

MediWound Ltd. - Common Shares (MDWD) Institutional Ownership

CUSIP: M68830104

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2023

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Type / Class
Equity / Common Shares
Symbol
MDWD on Nasdaq
Shares outstanding
12,838,938
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • MDWD - MediWound Ltd. - Common Shares is tracked under CUSIP M68830104.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 1 to 0 between Q4 2022 and Q1 2023.
  • Reported value moved from $479,633 to $0.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Official SEC Source

Backed by Schedule 13D/13G

Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.

See Original Filing

Investment Quick Answers

What is CUSIP M68830104?
CUSIP M68830104 identifies MDWD - MediWound Ltd. - Common Shares in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of MediWound Ltd. - Common Shares (MDWD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HOLD Alapkezelo Zrt. 8.1% +23% 1,039,954 +48% HOLD Alapkezelo Zrt. 13 Feb 2026
Rosalind Advisors, Inc. 7% 0% 912,319 0% Rosalind Advisors, Inc. 31 Dec 2025

Institutional Holders of MediWound Ltd. - Common Shares (MDWD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q1 0 $0 -$479,633 0
2022 Q4 36,502 $479,633 -$14,904,707 $13.14 1
2022 Q3 8,732,355 $12,156,900 +$7,886,736 $1.39 26
2022 Q2 3,060,032 $5,626,400 +$494,287 $1.84 19
2022 Q1 2,787,010 $5,545,527 -$1,735,379 $1.99 24
2021 Q4 3,655,370 $8,631,369 +$258,584 $2.36 27
2021 Q3 3,537,329 $11,810,598 -$1,010,498 $3.34 25
2021 Q2 3,555,747 $13,617,000 -$5,837,199 $3.83 23
2021 Q1 4,874,780 $26,170,480 +$652,531 $5.37 27
2020 Q4 4,815,044 $17,807,000 +$769,998 $3.70 26
2020 Q3 4,603,789 $17,306,000 +$273,265 $3.76 25
2020 Q2 4,541,601 $13,490,000 -$4,902,499 $2.97 23
2020 Q1 6,214,039 $9,756,000 -$982,416 $1.57 20
2019 Q4 6,818,630 $21,136,000 -$831,538 $3.10 23
2019 Q3 7,081,529 $22,565,000 -$2,317,194 $3.20 19
2019 Q2 7,812,066 $26,428,000 -$2,051,734 $3.38 24
2019 Q1 8,362,314 $41,812,000 +$1,415,133 $5.00 24
2018 Q4 8,111,968 $32,932,000 -$2,741,335 $4.06 21
2018 Q3 8,629,094 $53,199,185 -$1,620,579 $6.15 24
2018 Q2 8,809,937 $60,570,207 +$176,379 $6.90 19
2018 Q1 8,857,162 $46,061,156 -$153,501 $5.20 19
2017 Q4 8,889,781 $39,561,000 +$1,410,544 $4.45 22
2017 Q3 7,965,343 $42,498,000 +$14,965,316 $5.34 19
2017 Q2 5,152,069 $35,034,000 -$4,705,694 $6.80 19
2017 Q1 5,854,412 $38,639,000 -$638,538 $6.60 17
2016 Q4 6,004,784 $27,430,785 -$231,066 $4.58 20
2016 Q3 5,964,342 $45,921,090 -$21,022 $7.70 21
2016 Q2 5,785,106 $45,516,413 +$22,619,146 $7.89 18
2016 Q1 2,910,868 $23,489,719 +$44,635 $8.07 16
2015 Q4 2,903,686 $24,799,518 +$200,667 $8.54 18
2015 Q3 2,879,689 $21,970,890 +$2,483,340 $7.63 17
2015 Q2 2,555,675 $18,069,199 -$1,434,477 $7.07 17
2015 Q1 2,756,482 $20,149,213 +$803,653 $7.24 15
2014 Q4 2,650,826 $17,959,117 -$3,313,445 $6.66 16
2014 Q3 3,142,395 $19,716,000 -$4,131,129 $6.29 21
2014 Q2 3,581,061 $40,741,000 +$34,275,141 $11.38 21
2014 Q1 568,214 $8,188,000 +$8,188,000 $14.41 1

Sponsored